• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Is Obesity Linked to Weaker Uterine Contractility During Labor?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Hautakangas et al. (BJOG, 2022) investigated the impact of severe obesity (BMI ≥35 kg/m2) on uterine contractile activity 

METHODS: 

  • Exploratory, blinded analysis of a prospective cohort from a previous RCT 
  • Primary RCT compared intrauterine and external tocodynamometries and labor outcomes 
  • Population 
    • Singleton pregnancies 
    • ≥ 37 weeks 
    • Cephalic presentation 
    • Intrauterine tocodynamometry during labor 
  • Exposures 
    • Severe obesity: BMI ≥35 kg/m2  
  • Primary outcome 
    • Uterine contractile activity 
      • Assessed as intrauterine pressure, frequency of contractions and basal tonus of uterine muscle 
  • Secondary outcomes 
    • Use of oxytocin 
    • Labor outcomes 

RESULTS: 

  • 686 participants 
    • BMI ≥35 kg/m2: 84 participants 
  • Participants with obesity reached intrauterine pressure ≥200 MVUs during the first stage of labor more often than those with BMI <35 kg/m2 
    • BMI ≥35 kg/m2: 62% 
    • BMI <35 kg/m2: 49% 
    • OR 1.67 (95% CI, 1.05 to 2.67) 
  • Participants with obesity also had a higher basal tone of uterine muscle 
  • Women with obesity without a previous vaginal delivery  
    • Were more likely to fail to reach the active stage of labor  
      • OR 2.36 (95% CI, 2.39 to 4.37); P=0.005 
    • Were more likely to require cesarean 
      • OR 1.88 (95% CI, 1.08 to 3.27); P=0.024 
  • If a parturient had had previous vaginal delivery 
    • Obesity did not influence uterine activity 
    • There was no increased risk for caesarean 
  • Doses and total oxytocin amounts did not significantly differ between BMI groups 

CONCLUSION: 

  • Women with obesity were less likely to reach the active stage of labor and were more likely to require cesarean 
  • However, these outcomes are probably not due to decreased uterine contractile activity as uterine contractility was increased vs leaner participants 
  • The authors state 

The uterine contractile activity of obese parturients is equal to or even greater than that of leaner parturients, but obese parturients less often achieve vaginal delivery 

However, if the active stage of labour is reached, obese parturients have labours that are as straightforward as those among leaner parturients 

Learn More – Primary Sources: 

Impact of obesity on uterine contractile activity during labour: a blinded analysis of a randomised controlled trial cohort 

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Are Women with Obesity at Increased Risk for Failed Induction of Labor?
Are Obese Women Less Likely to Have Spontaneous Labor Onset?
Does Elective Induction Lower Risk for Adverse Obstetrical Outcomes in the Setting of Obesity

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site